false
OasisLMS
Catalog
ASGE Annual Postgraduate Course: Clinical Challeng ...
Healthcare AI Ethical Considerations for Personali ...
Healthcare AI Ethical Considerations for Personalized Care
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The video is a presentation on the topic of Ethics and Regulatory Affairs in AI, specifically focusing on Healthcare AI Ethical Considerations for Personalized Care. The speaker, Dr. Michael Abramoff, is a retina specialist and computer scientist who is also a professor at the University of Iowa. He is the founder and executive chairman of Digital Diagnostics, a company that created the first FDA-approved autonomous AI. In his presentation, Dr. Abramoff discusses the importance of autonomous AI in addressing healthcare disparities, particularly in the field of ophthalmology. He explains the difference between autonomous and assistive AI and highlights the potential benefits of autonomous AI in improving patient outcomes and addressing health disparities. Dr. Abramoff also emphasizes the need for ethical frameworks and regulatory oversight in the development and use of AI in healthcare. He discusses the challenges of healthcare AI, such as the scarcity of high-quality data and the need for data traceability. The presentation also covers topics like liability, stakeholder acceptance, and the importance of evaluating and validating AI systems. Dr. Abramoff concludes by discussing the positive impact of autonomous AI in addressing health disparities and the importance of a collaborative approach in the development and implementation of AI in healthcare.
Asset Subtitle
Michael Abramoff, MD
Keywords
Ethics
Regulatory Affairs
AI
Healthcare
Personalized Care
Autonomous AI
Health Disparities
×
Please select your language
1
English